Evidence Hub

Chondroid and Osseous Metaplasia of the Endometrium: A Tale of Two Rare Mesenchymal Metaplasia

Pujani M, Bhardwaj M, Dey A, Chauhan V, Singh V, Gupta T, Jandial C, Sharma P et al.

Gynecology and minimally invasive therapy, 2026

Abstract

Mesenchymal metaplasia of the endometrium is a rare phenomenon, characterized by the nonneoplastic cytomorphologic transformation of the uterine endometrial lining to ectopic bone/cartilage/fat/smooth muscle tissue/synovial tissue in the endometrium. Osseous metaplasia has an estimated incidence of 3/10,000, with around 100 cases documented in the literature. Most of the cases, it occurs following a pregnancy/abortion. The two most acceptable theories to account for its origin are first, bone metaplasia occurs from fetal bones that continue to develop leading to ossification, and second, multipotent stromal cells developing into chondroblasts/osteoblasts. Several factors play a role in the pathogenesis namely chronic endometritis, pyometra, tuberculosis, hyperkalcemia, etc., An accurate diagnosis of this lesion is crucial for surgical pathologists, as potential misdiagnosis as a malignant mixed Müllerian tumor, could result in overzealous treatment for a completely benign entity.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free